Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “PHARMAESSENTIA CORPORATION”

8 pharma patents match "PHARMAESSENTIA CORPORATION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 8
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 8 pharmaceutical patents matching "PHARMAESSENTIA CORPORATION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

8 results for “PHARMAESSENTIA CORPORATION” · 30,257 patents in full index Clear search

  1. US 12343381

    Dosage regimen for pegylated interferon

    PHARMAESSENTIA CORPORATION · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted

  2. US 11559567

    Dosage regimen for pegylated interferon

    PHARMAESSENTIA CORPORATION · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

  3. US 8765933

    Asynthesis of β-nucleosides

    PHARMAESSENTIA CORPORATION · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

  4. US 8617532

    Therapeutic use of interferon-polymer conjugates

    PHARMAESSENTIA CORPORATION · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  5. US 8273343

    Protein-polymer conjugates

    PHARMAESSENTIA CORPORATION · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  6. US 8193339

    Synthesis of β-nucleosides

    PHARMAESSENTIA CORPORATION · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

  7. US 8143214

    Protein-polymer conjugates

    PHARMAESSENTIA CORPORATION · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted

  8. US 8106160

    N-terminal modified interferon-alpha

    PHARMAESSENTIA CORPORATION · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.